White label ELPA - ClinicalTrials.eu

Study on Apocynin and Paeonol for Knee Osteoarthritis Pain Relief in Adults

Not recruiting

2 1 1
Investigated diseases:
- Osteoarthritis
Investigated drugs:
Study on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma

Not recruiting

2 1
Investigated diseases:
- Asthmatic crisis
Investigated drugs:
- Human Igg1 Kappa Monoclonal Antibody Against Crlf2
Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn’s Disease

Not recruiting

3 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Ozanimod
+9
Study of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma

Not recruiting

2 1 1
Investigated diseases:
- Cutaneous T-cell lymphoma
- Cutaneous T-cell lymphoma recurrent
Investigated drugs:
- Lacutamab
Study of ALX148 and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Pembrolizumab
Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Not recruiting

2 1
Investigated diseases:
- Cystic fibrosis
Investigated drugs:
+3
Study on Tirofiban and Aspirin for Patients with Acute Ischemic Stroke Due to Tandem Lesion

Not recruiting

3 1 1 1
Investigated diseases:
- Ischaemic stroke
Investigated drugs:
Study on Ribociclib, Alpelisib, and Letrozole for Adults with Advanced Hormone Receptor-Positive Breast Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Not recruiting

3 1 1 1
Investigated diseases:
- Metastatic malignant melanoma
Investigated drugs:
- Io102 Hydrochloride
- Pembrolizumab
+4
Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Not recruiting

3 1 1
Investigated diseases:
- Adenocarcinoma gastric
- Oesophageal adenocarcinoma
Investigated drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies